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It has been widely appreciated that the genome sequence
is shaping the future biomedical research. The genome
sequence provides a general framework for assembling
fragmentary DNA information into landscape of biolog-
ical structure and function [1]. The rapid advances in
DNA sequencing technology are revolutionizing biomedical
research.
Starting in 2005, a variety of massively parallel sequenc-
ing instruments such as the Roche/454,the Life Technologies
SOLiD, and the Illumina platforms which were largely
diﬀerent from the Sanger-based capillary sequencing were
used to sequence the human and model organism genomes.
Although each instrument has its own attributes, all mas-
sively parallel sequences machines share some common
remarkablefeatures[2].First,theinitialpreparatorystepsare
reduced and simpliﬁed. Second, ampliﬁcation of the library
fragments is needed for all platforms. Third, sequencing
reactions are performed and detected automatically. In the
pastdecade,theamountofsequenceoutputperrunhasbeen
dramatically increased, the per-base cost of DNA sequencing
has plummeted by ∼100,000-fold, and base-calling accuracy
has been largely improved. The current second-generation
sequencing machines can read ∼250 billion bases in a week.
When sequencing becomes simple and inexpensive,
it is being routinely applied to biomedical research. To
create comprehensive catalogues of genomic variants, the
next-generation sequencing technologies have been used
to produce sequence data in the 1000 Genomes Project.
It plans to sequence more than 2000 individuals to ﬁnd
essentially all single-nucleotide polymorphisms (SNPs),
insertions/deletions (indels), and structural variants with
frequency >1 %a c r o s st h eg e n o m ea n d>0.1% in protein-
coding regions. After the project is completed by 2012, the
full spectrum of human genomic variation in large, diverse
sample sets will have been identiﬁed. The further reduction
of cost and improvement of base-calling accuracy will
uncover the genetic architectures of complex diseases and
make clinical use of genome sequencing a routine practice
and create great opportunities for genomic medicine.
Many layers of epigenomic information are being
mapped by next-generation sequencing. Chromatic modi-
ﬁcation and protein binding can be mapped by chromatin
immunoprecipitation sequencing (ChIP-Seq). The genome-
wide single-base resolution of DNA methylation map has
beenperformedbybisulfatesequencing,inwhich themethy-
lated cytosines have been chemically modiﬁed. Massively
parallel sequencing have also been applied to microRNA
and mRNA proﬁling (RNA-Seq)to more accurately measure
expressions of microRNA and mRNA, identify variability in
microRNA sequence and mRNA sequence, and detect splice
form of mRNA expressions.
Massively parallel sequencing platforms have signiﬁ-
cantly increased our ability to study the human genome
and provided powerful new tools for genomic medicine.
However, these technologies have also required profound
changes to the data analysis. The major obstacle in genomic
research is no longer data production. The major challenge
in genome sequencing is the methods for data storages,2 Journal of Biomedicine and Biotechnology
transfer, and data analysis. The classical statistical methods
and computational algorithms are inadequate for analyzing
the unprecedented amount of genomic sequence data. Novel
analytic strategies for exploring new features of sequencing
data, integrating various genomic and epigenomic data,
unraveling the structure, organization, and function of the
human genome, understanding fundamental principles of
genomic biology, and discovering genetic and nongenetic
bases of diseases are urgently needed.
This special issue includes six high-quality papers, which
were selected after undergoing rigorous peer review. We
brieﬂy describe the papers in the following.
The ﬁrst paper (V. Costa et al., 2010) provides a com-
prehensive survey of the RNA sequencing methodology.
RNA sequencing is a major platform in the next-generation
sequencing (NGS), aiming to accurately determine expres-
sion levels of speciﬁc genes, diﬀerential splicing, and allele-
speciﬁc expression of transcripts at the transcriptome level.
So far, RNA sequencing remains the most complex (NGS)
application. The authors focus on the challenges that RNA
sequencing presents both from a biological and a bioinfor-
matics point of view.
In the second paper (Y. Qi et al., 2010), the authors apply
high-throughput sequencing of microRNAs in adenovirus
type 3 (AD3) infected human laryngeal epithelial (Hep2)
cells. Using the SOLiD sequencing technology, analysis of
microRNAs proﬁles identiﬁed 492 precursor microRNAs in
the AD3 infected Hep2 cells and 540 precursor microRNAs
in the control. Among them, 44 and 36 microRNAs showed
high and lower expression in the AD3 infected cells than
the control, respectively. The study demonstrates that NGS is
eﬃcient and powerful for microRNA proﬁling in the virus-
infected cell lines.
L. Cui et al. (2010) also apply SOLiD sequencing to pro-
ﬁle microRNAs involved in the host response to enterovirus
71 (EV71) infection. They found 64 microRNAs whose
expression levels changed from more than 2-fold in response
to EV71 infection in Hep2 cells. Functional analysis like
Gene Ontology enrichment test revealed that many of
these microRNAs might be involved in neurological process,
immune response, and cell death pathways, which have
known to be associated with the extreme virulence of EV71.
As authors stated, this is the ﬁrst paper on host microRNAs
expression alteration in response to EV71 infection.
W. Wang et al. (2010) use another NGS technology,
ChIP-Seq, to ﬁnd the targeting microRNA genes of a tran-
scription factor, EGR1, in human erythroleukemia cell line
K562. They found EGR1 binding sites near the promoters
of 124 distinct microRNA genes, accounting for about
42% of the miRNAs which have high-conﬁdence predicted
promoters (294). They also found that EGR1 binds to
another 63 pre-miRNAs. This study provides the ﬁrst global
binding proﬁle between the transcription factor EGR1 and
its targeting miRNA genes in PMA-treated K562 cells.
S. Hasson et al. (2010) report the cloning of cDNA
sequences encoding four groups or isoforms of the
haemostasis-disruptive Serine protease proteins (SPs) from
the venom glands of Echis ocellatus,w h o s eb i t ei st h e
leading cause of death and morbidity in Africa. Based on
their observation of the extraordinary level of interspeciﬁc
and intergeneric sequence conservation exhibited by the
Echis ocellatus EoSPs and analogous serine proteases from
other viper species, the authors speculate that antibodies
to representative molecules should neutralise the biological
function of this important group of venom toxins in vipers
that are distributed throughout Africa, the Middle East, and
the Indian subcontinent.
The last paper (Z. Zhao and C. Jiang 2010) conducts a
comparative genome-wide polymorphism-ﬁxation analysis
of human codons, as previously investigators often ana-
lyze either interspecies ﬁxed substitutions or intraspecies
nucleotide polymorphisms, but not both data types simul-
taneously. The authors report many features in the recent
codon evolution. They conclude that ﬁxation process could
eﬀectively and quickly correct the volatile changes intro-
duced by polymorphisms so that codon changes could be
gradual and directional and that codon composition could
be kept relatively stable during evolution. As numerous
mutation data have been identiﬁed by sequencing and many
more will be identiﬁed by NGS in the near future, such
analysis may help us understand mutational process in the
recent genome evolution.
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